Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06173778 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Semaglutide for Post-Smoking Cessation Weight Management

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 10 months later Jul 1, 2026 → May 25, 2028
See other at-risk trials from The University of Texas Health Science Center, Houston

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 1, 2026 to May 25, 2028
    • Study completion pushed from Aug 1, 2026 to Jun 25, 2028
    • Eligibility criteria expanded, about 45 words
    • Publications: details revised at 1 of 1 entry
  2. Re-verified, no change to tracked fieldsv4
  3. Study sites: 1 to 2v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2024 to Apr 23, 2024
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial will examine the effect of semaglutide 2.4mg on changes in body weight, body composition, and peripheral and central mechanisms that control appetite, satiety, and food intake in the context of smoking cessation.
Trial Details
NCT Number NCT06173778
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions
(from sponsor)		 Obesity, Overweight, Cigarette Smoking
Related terms Cigarette Smoking, Obesity, Overweight, Smoking
Enrollment 197 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov